Development of PARP and immune-checkpoint inhibitor combinations

165Citations
Citations of this article
131Readers
Mendeley users who have this article in their library.

Abstract

PARP inhibitors drive increased DNA damage, particularly in tumors with existing defects in DNA repair. This damage not only promotes immune priming through a range of molecular mechanisms, but also leads to adaptive upregulation of programmed death ligand 1 (PD-L1) expression. In this context, PARP inhibition and programmed cell death 1 (PD-1)/PD-L1–targeting antibodies represent a rationale combination. In this review, we detail the basic and translational science underpinning this promising new combination, summarize available clinical data, and discuss the key questions that remain to be addressed during future development.

References Powered by Scopus

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

10555Citations
N/AReaders
Get full text

Comprehensive molecular portraits of human breast tumours

9502Citations
N/AReaders
Get full text

PD-1 blockade in tumors with mismatch-repair deficiency

7708Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Combination strategies with PD-1/PD-L1 blockade: current advances and future directions

736Citations
N/AReaders
Get full text

The next decade of immune checkpoint therapy

455Citations
N/AReaders
Get full text

Poly(ADP-ribose) polymerase inhibition: past, present and future

360Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Stewart, R. A., Pilie, P. G., & Yap, T. A. (2018, December 15). Development of PARP and immune-checkpoint inhibitor combinations. Cancer Research. American Association for Cancer Research Inc. https://doi.org/10.1158/0008-5472.CAN-18-2652

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 45

60%

Researcher 17

23%

Professor / Associate Prof. 8

11%

Lecturer / Post doc 5

7%

Readers' Discipline

Tooltip

Medicine and Dentistry 42

55%

Biochemistry, Genetics and Molecular Bi... 21

28%

Agricultural and Biological Sciences 9

12%

Pharmacology, Toxicology and Pharmaceut... 4

5%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 1

Save time finding and organizing research with Mendeley

Sign up for free